(Q36909298)

English

PEG-asparaginase

scientific article published on August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

PEG-asparaginase. (English)

1 reference

Europe PubMed Central

17 August 2017

author name string

Cecilia H Fu

1

1 reference

Europe PubMed Central

17 August 2017

Kathleen M Sakamoto

2

1 reference

Europe PubMed Central

17 August 2017

language of work or name

0 references

publication date

1 August 2007

1 reference

Europe PubMed Central

17 August 2017

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

17 August 2017

8

1 reference

Europe PubMed Central

17 August 2017

12

1 reference

Europe PubMed Central

17 August 2017

1977-1984

1 reference

Europe PubMed Central

17 August 2017

An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Toxic and antineoplastic effects of L-asparaginase. Study of mice with lymphoma and normal monkeys and report on a child with leukemia.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Antitumor enzyme: polyethylene glycol-modified asparaginase

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Serum asparaginase activities and asparagine concentrations in the cerebrospinal fluid after a single infusion of 2,500 IU/m(2) PEG asparaginase in children with ALL treated according to protocol COALL-06-97.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Asparagine concentration in plasma after 2,500 IU/m(2) PEG-asparaginase i.v. in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Lack of asparagine depletion in the cerebrospinal fluid after one intravenous dose of PEG-asparaginase: a window study at initial diagnosis of childhood ALL

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Drug monitoring of PEG-asparaginase treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

High efficacy of monomethoxypolyethylene glycolconjugated l-asparaginase (PEG2-ASP) in two patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

A Phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Pegaspargase-induced pancreatitis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1977

21 January 2018

Identifiers

10.1517/14656566.8.12.1977

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36909298&oldid=2088563622"